Ori Barzilai1, Lily McLaughlin1, Mary-Kate Amato1, Anne S Reiner2, Shahiba Q Ogilvie1, Eric Lis3, Yoshiya Yamada4, Mark H Bilsky5, Ilya Laufer6. 1. Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. 2. Department of Epidemiology and Statistics, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. 3. Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. 4. Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. 5. Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA; Department of Neurological Surgery, Weill Cornell Medical College, New York, NY, USA. 6. Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA; Department of Neurological Surgery, Weill Cornell Medical College, New York, NY, USA. Electronic address: lauferi@mskcc.org.
Abstract
BACKGROUND CONTEXT: Surgical decompression and stabilization followed by radiosurgery represents an effective method for local tumor control and neurologic preservation for patients with metastatic epidural spinal cord compression (MESCC). We have previously demonstrated improvement in health-related quality of life (HrQOL) after this combined modality treatment ("hybrid therapy"). PURPOSE: The current analysis focuses on delineation of patient-specific prognostic factors predictive of HrQOL change after combined surgery-stereotactic radiosurgery (SRS) treatment of MESCC. STUDY DESIGN: This is a prospective, single-center, cohort study. PATIENT SAMPLE: One hundred and eleven patients with MESCC who underwent separation surgery followed by SRS were included. OUTCOME MEASURES: Prognostic factors associated with improved patient-reported outcome (PRO) measures. METHODS: Patient-reported outcome tools, that is, Brief Pain Inventory (BPI) and MD Anderson Symptom Inventory-Spine Tumor (MDASI-SP), both validated in the cancer population, were prospectively collected. Numeric prognostic factors were correlated with PRO measures using the Spearman rank correlation coefficient. Categorical prognostic factors were correlated with PRO measures using the Wilcoxon two-sample test (for two categories) or the Kruskal-Wallis test (for three or more categories). All statistical tests were two-sided with a level of significance <.05 for correlation of prognostic factors with PRO constructs and a level of significance <.0014 for correlation of prognostic factors with PRO items. Statistical analyses were done in SAS (version 9.4, Cary, NC, USA). RESULTS: One hundred and eleven patients were included in this analysis. Patients with lower preoperative Medical Research Council (MRC) motor scores experienced a greater decrease in symptom interference (BPI interference construct (p=.03) and individual functional measures including general activity (p=.001), walking (p=.001), and normal work (p=.006)). Lumbar location was associated with better outcomes than cervical or thoracic as noted on the BPI pain experience construct (p=.03) and MDASI-SP interference (p=.01) and core symptom (p=.002) constructs. Patients with American Spinal Injury Association (ASIA) scores of C or D benefit more than those with ASIA E on BPI interference construct (p=.04). Patients with higher Eastern Cooperative Oncology Group (ECOG) scores at presentation benefit more than those with low ECOG scores on MDASI-SP interference construct (p=.03). Women benefit more than men on BPI interference (p=.03) and pain experience (p=.04) constructs. Patients with prior spinal surgery at the current level of interest benefit less than those who are naïve surgical patients in MDASI-SP interference construct (p=.04). CONCLUSIONS: Delineation of patient characteristics associated with HrQOL improvement provides crucial information for patient selection, patient education, and setting treatment expectations. For patients with MESCC treated with hybrid therapy using surgery and radiosurgery, the presence of neurologic deficits and diminished performance status, lumbar tumor level, and female gender were associated with greater PRO improvement.
BACKGROUND CONTEXT: Surgical decompression and stabilization followed by radiosurgery represents an effective method for local tumor control and neurologic preservation for patients with metastatic epidural spinal cord compression (MESCC). We have previously demonstrated improvement in health-related quality of life (HrQOL) after this combined modality treatment ("hybrid therapy"). PURPOSE: The current analysis focuses on delineation of patient-specific prognostic factors predictive of HrQOL change after combined surgery-stereotactic radiosurgery (SRS) treatment of MESCC. STUDY DESIGN: This is a prospective, single-center, cohort study. PATIENT SAMPLE: One hundred and eleven patients with MESCC who underwent separation surgery followed by SRS were included. OUTCOME MEASURES: Prognostic factors associated with improved patient-reported outcome (PRO) measures. METHODS:Patient-reported outcome tools, that is, Brief Pain Inventory (BPI) and MD Anderson Symptom Inventory-Spine Tumor (MDASI-SP), both validated in the cancer population, were prospectively collected. Numeric prognostic factors were correlated with PRO measures using the Spearman rank correlation coefficient. Categorical prognostic factors were correlated with PRO measures using the Wilcoxon two-sample test (for two categories) or the Kruskal-Wallis test (for three or more categories). All statistical tests were two-sided with a level of significance <.05 for correlation of prognostic factors with PRO constructs and a level of significance <.0014 for correlation of prognostic factors with PRO items. Statistical analyses were done in SAS (version 9.4, Cary, NC, USA). RESULTS: One hundred and eleven patients were included in this analysis. Patients with lower preoperative Medical Research Council (MRC) motor scores experienced a greater decrease in symptom interference (BPI interference construct (p=.03) and individual functional measures including general activity (p=.001), walking (p=.001), and normal work (p=.006)). Lumbar location was associated with better outcomes than cervical or thoracic as noted on the BPI pain experience construct (p=.03) and MDASI-SP interference (p=.01) and core symptom (p=.002) constructs. Patients with American Spinal Injury Association (ASIA) scores of C or D benefit more than those with ASIA E on BPI interference construct (p=.04). Patients with higher Eastern Cooperative Oncology Group (ECOG) scores at presentation benefit more than those with low ECOG scores on MDASI-SP interference construct (p=.03). Women benefit more than men on BPI interference (p=.03) and pain experience (p=.04) constructs. Patients with prior spinal surgery at the current level of interest benefit less than those who are naïve surgical patients in MDASI-SP interference construct (p=.04). CONCLUSIONS: Delineation of patient characteristics associated with HrQOL improvement provides crucial information for patient selection, patient education, and setting treatment expectations. For patients with MESCC treated with hybrid therapy using surgery and radiosurgery, the presence of neurologic deficits and diminished performance status, lumbar tumor level, and female gender were associated with greater PRO improvement.
Authors: Xin Shelley Wang; Laurence D Rhines; Almon S Shiu; James N Yang; Ugur Selek; Ibrahima Gning; Ping Liu; Pamela K Allen; Syed S Azeem; Paul D Brown; Hadley J Sharp; David C Weksberg; Charles S Cleeland; Eric L Chang Journal: Lancet Oncol Date: 2012-01-27 Impact factor: 41.316
Authors: Terri S Armstrong; Ibrahima Gning; Tito R Mendoza; Elizabeth Vera-Bolanos; Mark R Gilbert; Laurence D Rhines; Jeffrey S Weinberg; Gisela Sanchez-Williams; Victor Levin; Allen W Burton; Charles Cleeland Journal: J Neurosurg Spine Date: 2010-04
Authors: Jennifer Moliterno; Clinton A Veselis; Michael A Hershey; Eric Lis; Ilya Laufer; Mark H Bilsky Journal: Spine J Date: 2014-03-12 Impact factor: 4.166
Authors: Kristin J Redmond; Simon S Lo; Scott G Soltys; Yoshiya Yamada; Igor J Barani; Paul D Brown; Eric L Chang; Peter C Gerszten; Samuel T Chao; Robert J Amdur; Antonio A F De Salles; Matthias Guckenberger; Bin S Teh; Jason Sheehan; Charles R Kersh; Michael G Fehlings; Moon-Jun Sohn; Ung-Kyu Chang; Samuel Ryu; Iris C Gibbs; Arjun Sahgal Journal: J Neurosurg Spine Date: 2016-11-11
Authors: Alexis Falicov; Charles G Fisher; Joe Sparkes; Michael C Boyd; Peter C Wing; Marcel F Dvorak Journal: Spine (Phila Pa 1976) Date: 2006-11-15 Impact factor: 3.468
Authors: Michael G Fehlings; Anick Nater; Lindsay Tetreault; Branko Kopjar; Paul Arnold; Mark Dekutoski; Joel Finkelstein; Charles Fisher; John France; Ziya Gokaslan; Eric Massicotte; Laurence Rhines; Peter Rose; Arjun Sahgal; James Schuster; Alexander Vaccaro Journal: J Clin Oncol Date: 2015-11-23 Impact factor: 44.544
Authors: Ilya Laufer; Scott L Zuckerman; Justin E Bird; Mark H Bilsky; Áron Lazáry; Nasir A Quraishi; Michael G Fehlings; Daniel M Sciubba; John H Shin; Addisu Mesfin; Arjun Sahgal; Charles G Fisher Journal: Spine (Phila Pa 1976) Date: 2016-10-15 Impact factor: 3.241
Authors: Ori Barzilai; Lily McLaughlin; Eric Lis; Anne S Reiner; Mark H Bilsky; Ilya Laufer Journal: Oper Neurosurg (Hagerstown) Date: 2019-05-01 Impact factor: 2.703
Authors: Andrew J Schoenfeld; Joseph H Schwab; Marco L Ferrone; Justin A Blucher; Tracy A Balboni; Lauren B Barton; John H Chi; James D Kang; Elena Losina; Jeffrey N Katz Journal: Clin Neurol Neurosurg Date: 2019-11-04 Impact factor: 1.876
Authors: Andrew J Schoenfeld; Marco L Ferrone; Peter G Passias; Justin A Blucher; Lauren B Barton; John H Shin; Mitchel B Harris; Joseph H Schwab Journal: Spine J Date: 2019-05-22 Impact factor: 4.166
Authors: Andrew J Schoenfeld; Marco L Ferrone; Joseph H Schwab; Justin A Blucher; Lauren B Barton; Mitchel B Harris; James D Kang Journal: Clin Neurol Neurosurg Date: 2019-04-22 Impact factor: 1.876
Authors: Andrew J Schoenfeld; Elena Losina; Marco L Ferrone; Joseph H Schwab; John H Chi; Justin A Blucher; Genevieve S Silva; Angela T Chen; Mitchel B Harris; James D Kang; Jeffrey N Katz Journal: Cancer Date: 2019-04-15 Impact factor: 6.860
Authors: Robert J Rothrock; Ori Barzilai; Anne S Reiner; Eric Lis; Adam M Schmitt; Daniel S Higginson; Yoshiya Yamada; Mark H Bilsky; Ilya Laufer Journal: Neurosurgery Date: 2021-01-13 Impact factor: 4.654
Authors: Ori Barzilai; Stefano Boriani; Charles G Fisher; Arjun Sahgal; Jorrit Jan Verlaan; Ziya L Gokaslan; Aron Lazary; Chetan Bettegowda; Laurence D Rhines; Ilya Laufer Journal: Global Spine J Date: 2019-05-08